Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 0 | 31 | 5 | 5 | 0 |
| Gross Profit | N/A | 31 | 5 | 5 | N/A |
| Operating Expenses | 24,244 | 28,919 | 20,864 | 22,927 | 21,820 |
| Operating Income | -24,244 | -28,893 | -20,859 | -22,922 | -21,815 |
| Interest Expense | 1,068 | 876 | 495 | 264 | 1 |
| Other Income | 2,749 | 2,411 | 2,340 | 1,040 | 1,560 |
| Pre-tax Income | -22,563 | -27,358 | -19,014 | -22,146 | -20,256 |
| Income Tax | N/A | N/A | N/A | N/A | -681 |
| Net Income Continuous | -22,563 | -27,358 | -19,014 | -22,146 | -19,575 |
| Net Income | $-22,563 | $-27,358 | $-19,014 | $-22,146 | $-19,575 |
| EPS Basic Total Ops | -0.18 | -0.26 | -0.21 | -0.27 | -0.26 |
| EPS Basic Continuous Ops | -0.18 | -0.26 | -0.21 | -0.27 | -0.26 |
| EPS Diluted Total Ops | -0.18 | -0.26 | -0.21 | -0.27 | -0.26 |
| EPS Diluted Continuous Ops | -0.18 | -0.26 | -0.21 | -0.27 | -0.26 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.27 | -0.21 | -0.27 | -0.26 |
| EBITDA(a) | $-24,873 | $-29,581 | $-20,915 | $-23,265 | $-22,477 |